ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,668, issued on July 15, was assigned to University of Pretoria (Pretoria, South Africa).

"Anticancer activity of Buddleja saligna compositions" was invented by Danielle Twilley (Johannesburg) and Namrita Lall (Pretoria, South Africa).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to an extract from Buddleja saligna, or a bioactive mixture consisting essentially of oleanolic acid and ursolic acid isolated from Buddleja saligna, for use in preventing and/or treating skin cancer, more specifically melanoma, and for reducing skin damage resulting from UV radiation. The invention also relates to uses and methods of treating skin canc...